ENZON PHARM INC ENZN (NASDAQ) $ 3.61 Change: -0.3 -8.31% | Volume: 1,006,063
Sponsored by Click here!
Headlines on ENZN
Alert me Subscribe

Enzon's Oncaspar-IV gets orphan status in Europe

(BRIDGEWATER, N.J.)Enzon Pharmaceuticals Inc. said Tuesday the newest version of its cancer drug Oncaspar has received orphan drug status in the European Union. Oncaspar-IV is a treatment for acute l...READ MORE
Sep 30, 2008 11:26AM
Keywords: ENZN

Enzon could sell its specialty pharma unit

(BRIDGEWATER, N.J.)Enzon Pharmaceuticals Inc. said Monday it could possibly sell its specialty pharmaceuticals unit as it moves forward with a spinoff of its biotechnology division.READ MORE
Aug 11, 2008 9:07AM
Keywords: ENZN

Enzon moves closer to spin-off with filing

(BRIDGEWATER, N.J.)Drug developer Enzon Pharmaceuticals Inc. on Thursday began its plan to spin off its biotechnology business by filing an outline of the proposed new company.READ MORE
Jul 31, 2008 7:36AM
Keywords: ENZN

Investor urges Enzon to consider sale of entire company

(NEW YORK)A shareholder of Enzon Pharmaceuticals Inc. has urged the drug maker to explore its strategic alternatives, including a sale of the entire company, according to a Securities and Ex...READ MORE
May 20, 2008 12:04PM
Keywords: ENZN


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +12.60 58.23
GILEAD SCIENCES -1.00 46.92
CELGENE CP -10.00 58.86
BIOGEN IDEC INC -31.90 43.52
AMYLIN PHARMA I -85.70 6.41